Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Salwen

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Molecular Cancer|June 8, 2010
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumorsAlexandre Chlenski, Lisa J Guerrero, Radhika Peddinti, et al.
Pediatric Blood & Cancer|December 8, 2011
Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growthNisha C Kakodkar, Radhika R Peddinti, Yufeng Tian, et al.
Oncotarget|October 25, 2016
Secreted protein acidic and rich in cysteine (SPARC) induces lipotoxicity in neuroblastoma by regulating transport of albumin complexed with fatty acidsAlexandre Chlenski, Marija Dobratic, Helen R Salwen, et al.
Cancer Research|December 25, 2002
SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesisAlexandre Chlenski, Shuqing Liu, Susan E Crawford, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1989
Characterization of a novel myeloma cell line, MM.1R E Goldman-Leikin, H R Salwen, C V Herst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCNS L Cohn, W B London, D Huang, et al.
Oncogene|January 23, 2004
MYCN-mediated regulation of the MRP1 promoter in human neuroblastomaChitra F Manohar, James A Bray, Helen R Salwen, et al.
Pediatric Blood & Cancer|September 23, 2010
The quinoxaline anti-tumor agent (R+)XK469 inhibits neuroblastoma tumor growthNisha C Kakodkar, Radhika Peddinti, Morris Kletzel, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 1, 1987
Establishment and characterization of a neuroendocrine skin carcinoma cell lineS T Rosen, V E Gould, H R Salwen, et al.
Plos One|September 28, 2011
Secreted protein acidic and rich in cysteine is a matrix scavenger chaperoneAlexandre Chlenski, Lisa J Guerrero, Helen R Salwen, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Molecular Cancer|June 8, 2010
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumorsAlexandre Chlenski, Lisa J Guerrero, Radhika Peddinti, et al.
Pediatric Blood & Cancer|December 8, 2011
Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growthNisha C Kakodkar, Radhika R Peddinti, Yufeng Tian, et al.
Oncotarget|October 25, 2016
Secreted protein acidic and rich in cysteine (SPARC) induces lipotoxicity in neuroblastoma by regulating transport of albumin complexed with fatty acidsAlexandre Chlenski, Marija Dobratic, Helen R Salwen, et al.
Cancer Research|December 25, 2002
SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesisAlexandre Chlenski, Shuqing Liu, Susan E Crawford, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1989
Characterization of a novel myeloma cell line, MM.1R E Goldman-Leikin, H R Salwen, C V Herst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCNS L Cohn, W B London, D Huang, et al.
Oncogene|January 23, 2004
MYCN-mediated regulation of the MRP1 promoter in human neuroblastomaChitra F Manohar, James A Bray, Helen R Salwen, et al.
Pediatric Blood & Cancer|September 23, 2010
The quinoxaline anti-tumor agent (R+)XK469 inhibits neuroblastoma tumor growthNisha C Kakodkar, Radhika Peddinti, Morris Kletzel, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 1, 1987
Establishment and characterization of a neuroendocrine skin carcinoma cell lineS T Rosen, V E Gould, H R Salwen, et al.
Plos One|September 28, 2011
Secreted protein acidic and rich in cysteine is a matrix scavenger chaperoneAlexandre Chlenski, Lisa J Guerrero, Helen R Salwen, et al.
Pageof 5